证券代码：601008 证券简称：连云港 公告编号：临 2025-045 江苏连云港港口股份有限公司 《上海证券交易所上市公司自律监管指引第 1 号--规范运作》 以及《公司章程》的有关规定，王新文先生、吴治明先生的离任自公司收到辞职 报告之日起生效，其离任不会导致公司董事会成员低于法定最低人数，不会影响 公司董事会正常运作。公司将按照《公司法》、 《公司章程》等相关规定尽快完成 关于公司董事离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事提前离任基本情况 到董事王新文先生、董事吴治明先生提交的书面辞职报告。王新文先生、吴治明 先生因工作原因申请辞去公司董事并战略委员会委员职务，具体情况如下： | | | | | 是否继续在 | 具 | 是否存在 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 原定任期 | 离任 | 上市公司及 | 体 | 未履行完 | | 姓名 | 离任职务 | 离任时间 | | | | | | | | | | ...

Group 1 - The company announced the resignation of two directors, Wang Xinwen and Wu Zhiming, due to work-related reasons, effective August 12, 2025 [2] - For the year 2024, the company's revenue composition is as follows: 76.24% from loading and related services, 17.87% from shipping and other services, 4.12% from financial services, and 1.76% from other businesses [2]

Core Viewpoint - The company announced the resignation of two board members, Wang Xinwen and Wu Zhiming, due to work-related reasons, effective immediately upon delivery of their resignation letters to the board [1] Group 1 - Wang Xinwen has resigned from his positions as director and vice chairman of the company [1] - Wu Zhiming has resigned from his position as a director of the company [1] - Both resignations indicate a significant change in the company's board composition [1]

一、董事提前离任基本情况 证券代码：601008 证券简称：连云港 公告编号：临 2025-045 江苏连云港港口股份有限公司 关于公司董事离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏连云港港口股份有限公司董事会 2025 年 8 月 12 日，江苏连云港港口股份有限公司（以下简称"公司"）收 到董事王新文先生、董事吴治明先生提交的书面辞职报告。王新文先生、吴治明 先生因工作原因申请辞去公司董事并战略委员会委员职务，具体情况如下： 2025 年 8 月 13 日 根据《公司法》、《上海证券交易所上市公司自律监管指引第 1 号--规范运作》 以及《公司章程》的有关规定，王新文先生、吴治明先生的离任自公司收到辞职 报告之日起生效，其离任不会导致公司董事会成员低于法定最低人数，不会影响 公司董事会正常运作。公司将按照《公司法》、《公司章程》等相关规定尽快完成 新任董事的补选工作。 公司董事会对王新文先生以及吴治明先生任职期间为公司做出的贡献表示 衷心的感谢！ 特此公告。 | 姓名 | 离任职务 | 离任时间 | ...

2025年1月-3月，连云港实现营业收入6.09亿元，同比减少4.18%；归属净利润2279.43万元，同比减少 48.01%。 资料显示，江苏连云港港口股份有限公司位于中国(江苏)自由贸易实验区连云港片区连云区庙岭港区港 口四路8号，公司主要从事海港码头货物装卸、客货班轮运输、堆存及港务管理业务、商品质押融资、 期货交割等业务，是中国的重要港口装卸业务板块和资本运作战略平台。截至2021年末，公司股本规模 12.41亿股、资产规模92.48亿元，下属分公司和参控股公司11家，拥有28个通用和专业化泊位，参股经 营3个通用泊位、4个集装箱泊位，控股经营两条中韩客货班轮航线。 截至3月31日，连云港股东户数5.79万，人均流通股2.14万股。 8月12日，连云港盘中上涨5.79%，截至11:11，报6.39元/股，成交3.74亿元，换手率4.85%，总市值79.28 亿元。 ...

Company Overview - Lianyungang Huiyao Medical Equipment Co., Ltd. has recently been established with a registered capital of 2 million RMB [1] - The legal representative of the company is Han Weiwei [1] Business Scope - The company is authorized to operate Class III medical devices, which require approval from relevant authorities before business activities can commence [1] - General business activities include the sale of Class I and Class II medical devices, sales of sanitary products and disposable medical supplies, wholesale of protective gear for medical personnel, and sales of daily necessities [1] - Additional services include the sale and repair of office equipment, rental services for transportation equipment, sales of machinery and specialized equipment, and wholesale of medical masks [1]

Core Insights - The major projects in Lianyungang have shown significant progress in the first half of the year, with a construction rate of 85.7% and an investment completion of 86.07 billion yuan, surpassing previous years' performance [1][2] Group 1: Project Performance - Lianyungang's major projects have achieved a construction rate of 85.7% in the first half of the year, with 517 key industrial projects completing investments of 86.07 billion yuan [1] - The industrial projects, totaling 387, focus on sectors such as new energy and new materials, aligning with Lianyungang's strategy of "industrial city, strong industry" [1] - The EVA production facility of Shenghong Chemical has reached a monthly capacity of 60,000 tons, with all products pre-sold before production [1] Group 2: Economic Development Support - The city has implemented a comprehensive service system to support project initiation, construction, and completion, ensuring timely approvals and resource allocation [2] - The NuoTai long-chain polypeptide drug production project in Lianyungang is set to achieve an annual sales revenue of 2 billion yuan and tax revenue of 200 million yuan upon full operation [2] - The government has organized financing events, identifying 45 projects with a total funding requirement of 8.29 billion yuan [3] Group 3: Cost Reduction Initiatives - Lianyungang has introduced measures to lower operational costs for enterprises, including a natural gas pricing policy that saved companies approximately 28 million yuan in the first half of the year [3] - The implementation of smart AI ozone dosing and resource optimization in wastewater treatment has reduced costs for enterprises by approximately 5.35 million yuan [3]

Core Viewpoint - Lianyungang Jiuzhiye New Material Technology Co., Ltd. has been established with a registered capital of 300,000 RMB, focusing on various new material technologies and related services [1] Company Overview - The legal representative of the company is Wang Sumei [1] - The registered capital is 300,000 RMB [1] Business Scope - The company engages in general projects including new material technology promotion services, sales agency, and chemical product sales (excluding licensed chemical products) [1] - It also sells coatings, pigments, dyes, surface functional materials, and specialized chemical products (excluding hazardous chemicals) [1] - Additional services include anti-corrosion materials sales, thermal insulation materials sales, handling and transportation, labor services (excluding labor dispatch), and various technical services such as consulting, development, and transfer [1] - The company provides information technology consulting, safety consulting, engineering management services, digital technology services, and wholesale of computer hardware and software [1] - Other activities include sales of electronic products, automotive decoration supplies, laboratory analysis instruments, conference and exhibition services, marketing planning, and financial consulting (excluding projects requiring approval) [1]

Group 1 - A new company named Lianyungang Dongshun Chemical Technology Co., Ltd. has been established with a registered capital of 1 million RMB [1] - The legal representative of the company is Sun Weidong [1] - The company's business scope includes general projects such as new material technology promotion services, chemical product sales (excluding licensed chemical products), and specialized chemical product sales (excluding hazardous chemicals) [1] Group 2 - The company is also involved in the research and development of biological pesticides and offers various technical services including consulting, development, and technology transfer [1] - Additional business activities include the sale of petroleum products (excluding hazardous chemicals) and coatings (excluding hazardous chemicals) [1] - The company is permitted to operate independently based on its business license, except for projects that require approval [1]

Company Announcements - Jihua Group's main business and existing product system do not involve brain-computer interface related fields [1] - Hongjing Optoelectronics plans to invest 1.533 billion yuan to build a research and manufacturing headquarters project [1] - Zhuojin Co., Ltd. won the bid for soil control project around Longchao Line [1] - Jianghuai Automobile's July sales totaled 25,197 units, a year-on-year decrease of 21.73% [1][2] - Lakala intends to transfer 100% equity of certain subsidiaries [1] - Haitai High-tech completed a buyback, spending a total of 70.91 million yuan to repurchase 6.69995 million shares [1] - Tongchen Beijian reported a net profit of 737 million yuan for the first half of the year, a year-on-year decrease of 17.34% [1][3] - Xuelang Environment's shareholders plan to reduce their holdings by a total of no more than 3% [1] - Huaxia Happiness's shareholders plan to reduce their holdings by a total of no more than 3% [1] - Sanxin Medical plans to issue convertible bonds to raise no more than 530 million yuan [1] - *ST Gaohong's stock may face mandatory delisting due to major legal violations [1] Investment and Financial Data - GAC Group's July automobile sales were 119,482 units, a year-on-year decrease of 15.38% [2] - Minghe Co., Ltd. reported July sales revenue of 41.36 million yuan [2] - Tangrenshen's July pig sales revenue totaled 589.6 million yuan [3] - Tiankang Biological's July pig sales revenue was 335 million yuan [3] - Chongqing Construction's new contract amount for the first half of the year was 24.271 billion yuan, a year-on-year decrease of approximately 19.20% [3] Shareholder Actions - Guangdong Hongda's subsidiary plans to acquire 60% equity of Changzhilin [3] - Ningbo Energy intends to acquire a total of 41% equity of Yongneng Comprehensive Energy [3] - Tianyang Technology plans to invest to acquire 51% equity of Moshuzhiqing [3] - ST Lutong's specific shareholders plan to reduce their holdings by a total of no more than 3.27% [3] - Jiuliang Co., Ltd.'s shareholders plan to reduce their holdings by a total of no more than 3% [3] - Ailis's employee stock ownership platform plans to reduce a total of no more than 13.5 million shares [3] - Huaxia Happiness's shareholders plan to reduce their holdings by a total of no more than 3% [3] Other Developments - Sanxin Medical plans to use the raised funds for the expansion project of producing 10 million blood dialysis membranes and 10 million blood dialysis devices [3]